Showing results (411-420 of 483) with videos related to

Sort By:
Pageof 49
Haematologica|April 5, 2015
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trialMaximilian Merz, Hans Salwender, Mathias Haenel, et al.
European Journal of Haematology|April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsEMarc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
The Lancet. Oncology|September 7, 2013
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trialJesus San Miguel, Katja Weisel, Philippe Moreau, et al.
European Heart Journal. Cardiovascular Imaging|January 20, 2023
Pulmonary transit time of cardiovascular magnetic resonance perfusion scans for quantification of cardiopulmonary haemodynamicsMartin Segeroth, David Jean Winkel, Ivo Strebel, et al.
Bioengineering (Basel, Switzerland)|March 28, 2026
AI-Based Myocardial Segmentation and Attenuation Mapping Improved Detection of Myocardial Ischemia and Infarction on Emergency CT AngiographyMartin Segeroth, Jan Vosshenrich, Hanns-Christian Breit, et al.
The Lancet. Haematology|October 9, 2022
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trialSagar Lonial, Rakesh Popat, Cyrille Hulin, et al.
Advances in Therapy|August 6, 2025
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple MyelomaCyrille Touzeau, Brea Lipe, Abdullah M Khan, et al.
Immunotherapy|November 24, 2020
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparisonPhilippe Moreau, Benjamin Hebraud, Thierry Facon, et al.
Colloids and Surfaces. B, Biointerfaces|July 23, 2025
Thermodynamic and electron paramagnetic resonance descriptors of TiO2 nanoforms interaction with plasma albumin: The interplay between energetic parameters and nanomaterial's toxicityDaniela Gheorghe, Aurica Precupas, Alina Botea-Petcu, et al.
The European Respiratory Journal|August 21, 2020
Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trialJürgen Hetzel, Athol U Wells, Ulrich Costabel, et al.
Pageof 49